U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU&CD3 Antibody (AMX-818)Cat. No. WA1648Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU&CD3 Antibody (AMX-818)Cat. No. WA1648
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (ZW49)Cat. No. WA1647
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (ZW33)Cat. No. WA1646
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (ZV0201)Cat. No. WA1645
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (XMT-1522)Cat. No. WA1644
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (VB7-756)Cat. No. WA1643
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (TAA013)Cat. No. WA1642
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (T1E28z)Cat. No. WA1641
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (SYD983)Cat. No. WA1640
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (SC-007)Cat. No. WA1639
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (SBT6050)Cat. No. WA1638
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (PF-06888667)Cat. No. WA1637